10 likes | 146 Views
Figure 2 Features of subclinical or indolent ABMR, which is typically diagnosed in protocol biopsies performed at 3 months or 1 year after transplantation in kidney transplant recipients who have preformed DSAs and are receiving potent immunosuppressive conditioning.
E N D
Figure 2Features of subclinical or indolent ABMR, which is typically diagnosed in protocol biopsies performed at 3 months or 1 year after transplantation in kidney transplant recipients who have preformed DSAs and are receiving potent immunosuppressive conditioning Loupy, A. et al.(2012) The impact of donor-specific anti-HLA antibodies on late kidney allograft failure Nat. Rev. Nephrol. doi:10.1038/nrneph.2012.81